Eliminating Disparities in Cardiovascular Disease for Black Women: JACC Review Topic of the Week.

Autor:	Ogunniyi MO; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA; Grady Health System, Atlanta, Georgia, USA. Electronic address: modele.ogunniyi@emory.edu., Mahmoud Z; Division of Cardiology, Department of Medicine, Washington University in St. Louis, Missouri, USA. Electronic address: https://twitter.com/DrZMahmoud., Commodore-Mensah Y; Johns Hopkins School of Nursing, Baltimore, Maryland, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Electronic address: https://twitter.com/ycommodore., Fleg JL; Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA., Fatade YA; J. Willis Hurst Internal Medicine Residency, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: https://twitter.com/joyfuldockemi., Quesada O; Women's Heart Center, The Christ Hospital Heart and Vascular Institute, Cincinnati, Ohio, USA; The Carl and Edyth Lindner Center for Research and Education, The Christ Hospital, Cincinnati, Ohio, USA. Electronic address: https://twitter.com/odayme., Aggarwal NR; Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: https://twitter.com/NitiCardio., Mattina DJ; Division of Regional Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: https://twitter.com/drladyheart., Moraes De Oliveira GM; Univiersidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address: https://twitter.com/glauciamoraeso1., Lindley KJ; Division of Cardiology, Department of Medicine, Washington University in St. Louis, Missouri, USA. Electronic address: https://twitter.com/DrKLindley., Ovbiagele B; Department of Neurology, University of California, San Francisco, California, USA., Roswell RO; Department of Cardiology, Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, Northwell Health, New York, New York, USA. Electronic address: https://twitter.com/DrRobRoswell., Douglass PL; Wellstar Center for Cardiovascular Care, Wellstar Atlanta Medical Center, Atlanta, Georgia, USA., Itchhaporia D; Department of Cardiology, Hoag Hospital, University of California, Irvine, California, USA. Electronic address: https://twitter.com/ditchhaporia., Hayes SN; Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: https://twitter.com/SharonneHayes.
Jazyk:	angličtina
Zdroj:	Journal of the American College of Cardiology [J Am Coll Cardiol] 2022 Nov 01; Vol. 80 (18), pp. 1762-1771.
DOI:	10.1016/j.jacc.2022.08.769
Abstrakt:	Black women are disproportionately affected by cardiovascular disease with an excess burden of cardiovascular morbidity and mortality. In addition, the racialized structure of the United States shapes cardiovascular disease research and health care delivery for Black women. Given the indisputable evidence of the disparities in health care delivery, research, and cardiovascular outcomes, there is an urgent need to develop and implement effective and sustainable solutions to advance cardiovascular health equity for Black women while considering their ethnic diversity, regions of origin, and acculturation. Innovative and culturally tailored strategies that consider the differential impact of social determinants of health and the unique challenges that shape their health-seeking behaviors should be implemented. A patient-centered framework that involves collaboration among clinicians, health care systems, professional societies, and government agencies is required to improve cardiovascular outcomes for Black women. The time is "now" to achieve health equity for all Black women. Competing Interests: Funding Support and Author Disclosures Dr Ogunniyi has received institutional research grants from AstraZeneca, Boehringer Ingelheim, and Zoll; and has been an advisory board member for Pfizer. Dr Fatade is supported by the Stimulating Access to Research in Residency of the National Institutes of Health under award number R38AI140299. Dr Quesada is supported by the National Institutes of Health under award number K23 HL151867. Dr Mattina has received speaker fees from Zoll. Dr Ovbiagele is supported by research grants from the National Institutes of Health; and is a consultant and an advisory board member for AstraZeneca. The contents of this paper are solely the responsibility of the authors and do not necessarily represent official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the U.S. Department of Health and Human Services. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Copyright © 2022 American College of Cardiology Foundation. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu